None of the MBC cases in our cohort were found to have HER2 over-expression, which was also consistent with previous studies showing that MBCs are less likely to express HER2 receptors compared to FBC (9% vs. 15%, respectively) [5,7]. Here, ERBB2 is linked to maternal uniparental disomy of chromosome 20.